{
    "nct_id": "NCT05310448",
    "official_title": "Tumor Treating Fields: Pilot Study of Adjuvant Treatment for Brainstem Gliomas",
    "brief_title": "Tumor Treating Fields for the Treatment of Brainstem Gliomas",
    "cancer_type_display": "A pilot study evaluating the safety and efficacy of Tumor Treating Fields for patients with brainstem gliomas.",
    "cancer_tags": [
      "Glioma"
    ],
    "link_to_trial": "https://clinicaltrials.gov/study/NCT05310448",
    "phase": "NA",
    "recruitment_status": "RECRUITING",
    "last_update_date": "2025-09-26",
    "enrollment": 10,
    "min_age": 18,
    "max_age": null,
    "sex": "ALL",
    "is_metastatic_allowed": null,
    "performance_status_scale": "Karnofsky",
    "performance_status_values": [
      70,
      80,
      90,
      100
    ],
    "min_prior_lines": null,
    "max_prior_lines": null,
    "prior_treatments_required": [
      "Surgery",
      "Radiotherapy"
    ],
    "prior_treatments_excluded": [
      "Receiving any other investigational agents or an investigational device within 21 days"
    ],
    "principal_investigator": "Jim Zhong, MD",
    "site_name": "Emory Proton Therapy Center",
    "contact_email": "india.eunhye.green@emoryhealthcare.org",
    "contact_phone": "404-778-1738",
    "locations": [
      {
        "facility": "Emory Proton Therapy Center",
        "status": "NOT_YET_RECRUITING",
        "city": "Atlanta",
        "state": "Georgia",
        "zip": "30308",
        "country": "United States",
        "contacts": [
          {
            "name": "India Green",
            "role": "CONTACT",
            "phone": "404-778-1738",
            "email": "india.eunhye.green@emoryhealthcare.org"
          },
          {
            "name": "Jim Zhong, MD",
            "role": "PRINCIPAL_INVESTIGATOR"
          }
        ],
        "geoPoint": {
          "lat": 33.749,
          "lon": -84.38798
        }
      },
      {
        "facility": "Emory University/Winship Cancer Institute",
        "status": "RECRUITING",
        "city": "Atlanta",
        "state": "Georgia",
        "zip": "30322",
        "country": "United States",
        "contacts": [
          {
            "name": "India Green",
            "role": "CONTACT",
            "phone": "404-778-1738",
            "email": "india.eunhye.green@emoryhealthcare.org"
          },
          {
            "name": "Jim Zhong, MD",
            "role": "PRINCIPAL_INVESTIGATOR"
          }
        ],
        "geoPoint": {
          "lat": 33.749,
          "lon": -84.38798
        }
      },
      {
        "facility": "Emory Saint Joseph's Hospital",
        "status": "NOT_YET_RECRUITING",
        "city": "Atlanta",
        "state": "Georgia",
        "zip": "30342",
        "country": "United States",
        "contacts": [
          {
            "name": "India Green",
            "role": "CONTACT",
            "phone": "404-778-1738",
            "email": "india.eunhye.green@emoryhealthcare.org"
          },
          {
            "name": "Jim Zhong, MD",
            "role": "PRINCIPAL_INVESTIGATOR"
          }
        ],
        "geoPoint": {
          "lat": 33.749,
          "lon": -84.38798
        }
      }
    ],
    "key_inclusion_summary": [
      "Age >= 18 years.",
      "Karnofsky performance status >= 70%.",
      "Diagnosis of glioma with at least partial involvement of the brainstem.",
      "Completion of all previous therapy (including surgery and radiotherapy) for the treatment of cancer >= 4 weeks before the start of study therapy.",
      "Adequate organ and marrow function."
    ],
    "key_exclusion_summary": [
      "Completed chemotherapy or radiotherapy more than 26 weeks prior to entering the study.",
      "Receiving any other investigational agents or an investigational device within 21 days before first administration of study device.",
      "History of allergic reactions attributed to compounds of similar composition to those used for transducer placement.",
      "Uncontrolled intercurrent illness or significant cardiovascular disease.",
      "HIV-positive patients on combination antiretroviral therapy."
    ]
  }